Integra Lifesciences Holdings (IART) Interest & Investment Income (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Interest & Investment Income data on file, last reported at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 7.1% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $18.2 million (down 6.49% YoY), and the FY2025 full-year result was $18.5 million, down 7.81% from the prior year.
• Interest & Investment Income slipped to $4.1 million in Q1 2026, from $4.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $5.3 million in Q4 2022 to a low of $1.4 million in Q1 2022.
• A 5-year average of $4.2 million and a median of $4.5 million in 2023 frame the typical range for Interest & Investment Income.
• Peak annual rise in Interest & Investment Income reached 269.08% in 2022, while the deepest fall reached 21.22% in 2022.
• Tracing IART's Interest & Investment Income over 5 years: stood at $5.3 million in 2022, then decreased by 14.35% to $4.5 million in 2023, then climbed by 7.56% to $4.9 million in 2024, then retreated by 10.85% to $4.4 million in 2025, then declined by 5.87% to $4.1 million in 2026.
• Business Quant data shows IART's Interest & Investment Income at $4.1 million in Q1 2026, $4.4 million in Q4 2025, and $5.0 million in Q3 2025.